The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
MeSH Review

Menstrual Cycle

Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of Menstrual Cycle


Psychiatry related information on Menstrual Cycle


High impact information on Menstrual Cycle


Chemical compound and disease context of Menstrual Cycle


Biological context of Menstrual Cycle


Anatomical context of Menstrual Cycle

  • Using this SIVmac model, we found that subcutaneous progesterone implants, which could mimic hormonally based contraceptives, thinned the vaginal epithelium and enhanced SIV vaginal transmission 7.7-fold over that observed in macaques treated with placebo implants and exposed to SIV in the follicular phase of the menstrual cycle [26].
  • Since a short luteal phase is associated with an endometrium not conductive to implantation, administration of the LRF agonist at the onset of menstrual cycle may prove to be a practical and novel approach to fertility control [27].
  • The clinical implications of these primate studies may be far-reaching because they indicate new potential for childbearing by otherwise infertile or sterile women who have a competent uterus but lack the hormonal milieu provided by ovarian follicular maturation and corpus luteum function in the normal menstrual cycle [28].
  • 43 subfertile men with circulating antibodies to spermatozoa entered a double-blind crossover trial and received soluble prednisolone (20 mg twice daily on days 1-10 of the female partner's menstrual cycle, followed by 5 mg on days 11 and 12) or matching placebo tablets for 9 months each [29].
  • Erythrocyte filterability, reticulocyte count, total serum bilirubin, and CO hemoglobin percent saturation (COHb) were measured throughout one menstrual cycle in 17 women [30].

Associations of Menstrual Cycle with chemical compounds

  • This suggested that giving a single dose of RU 486 late in the menstrual cycle might be an effective contraceptive strategy [31].
  • OBJECTIVES: To determine if the degree of QT prolongation in response to ibutilide varies with the menstrual cycle phase and to compare QT prolongation between women and men [21].
  • This action of estradiol provides an explanation for the selective reduction in FSH responses to GnRH seen during pubertal maturation in girls and during the mid-follicular stage of the menstrual cycle [32].
  • Both in follicular and luteal phases of the menstrual cycle, the women with lower SES had 50% higher estriol ratios (ratio of the concentration of estriol to the sum of the concentrations of estrone and estradiol) [33].
  • Thirty-four premenopausal women, aged 21-40 years, with a history of regular menstrual cycles, consumed 30 g of ethanol (equivalent to approximately two average drinks) per day for three menstrual cycles and no alcohol for the other three [34].

Gene context of Menstrual Cycle


Analytical, diagnostic and therapeutic context of Menstrual Cycle


  1. Comparison of urinary and plasma hormone levels in daughters of breast cancer patients and controls. Pike, M.C., Casagrande, J.T., Brown, J.B., Gerkins, V., Henderson, B.E. J. Natl. Cancer Inst. (1977) [Pubmed]
  2. Accelerated puberty and late-onset hypothalamic hypogonadism in female transgenic skinny mice overexpressing leptin. Yura, S., Ogawa, Y., Sagawa, N., Masuzaki, H., Itoh, H., Ebihara, K., Aizawa-Abe, M., Fujii, S., Nakao, K. J. Clin. Invest. (2000) [Pubmed]
  3. Altered waveform of plasma nocturnal melatonin secretion in premenstrual depression. Parry, B.L., Berga, S.L., Kripke, D.F., Klauber, M.R., Laughlin, G.A., Yen, S.S., Gillin, J.C. Arch. Gen. Psychiatry (1990) [Pubmed]
  4. Plasminogen activator inhibitor 1 messenger RNA expression and molecular evidence for del(7)(q22) in uterine leiomyomas. Sourla, A., Polychronakos, C., Zeng, W.R., Nepveu, A., Kukuvitis, A., Naud, F., Koutsilieris, M. Cancer Res. (1996) [Pubmed]
  5. Effects of the menstrual cycle on medical disorders. Case, A.M., Reid, R.L. Arch. Intern. Med. (1998) [Pubmed]
  6. Postnatal gonadal steroid effects on human behavior. Rubin, R.T., Reinisch, J.M., Haskett, R.F. Science (1981) [Pubmed]
  7. A menstruation-linked periodic hypersomnia. Kleine-Levin syndrome or new clinical entity? Billiard, M., Guilleminault, C., Dement, W.C. Neurology (1975) [Pubmed]
  8. Bone density at weight-bearing and nonweight-bearing sites in ballet dancers: the effects of exercise, hypogonadism, and body weight. Young, N., Formica, C., Szmukler, G., Seeman, E. J. Clin. Endocrinol. Metab. (1994) [Pubmed]
  9. Relationship between serum hormone concentrations, reproductive history, alcohol consumption and genetic polymorphisms in pre-menopausal women. García-Closas, M., Herbstman, J., Schiffman, M., Glass, A., Dorgan, J.F. Int. J. Cancer (2002) [Pubmed]
  10. Prolactin response to fenfluramine and suicide attempt lethality in major depression. Malone, K.M., Corbitt, E.M., Li, S., Mann, J.J. The British journal of psychiatry : the journal of mental science. (1996) [Pubmed]
  11. Fluoxetine in the treatment of premenstrual dysphoria. Canadian Fluoxetine/Premenstrual Dysphoria Collaborative Study Group. Steiner, M., Steinberg, S., Stewart, D., Carter, D., Berger, C., Reid, R., Grover, D., Streiner, D. N. Engl. J. Med. (1995) [Pubmed]
  12. Polycystic ovaries and hyperandrogenism in women taking valproate for epilepsy. Isojärvi, J.I., Laatikainen, T.J., Pakarinen, A.J., Juntunen, K.T., Myllylä, V.V. N. Engl. J. Med. (1993) [Pubmed]
  13. Lack of effect of induced menses on symptoms in women with premenstrual syndrome. Schmidt, P.J., Nieman, L.K., Grover, G.N., Muller, K.L., Merriam, G.R., Rubinow, D.R. N. Engl. J. Med. (1991) [Pubmed]
  14. Artificially induced endometrial cycles and establishment of pregnancies in the absence of ovaries. Navot, D., Laufer, N., Kopolovic, J., Rabinowitz, R., Birkenfeld, A., Lewin, A., Granat, M., Margalioth, E.J., Schenker, J.G. N. Engl. J. Med. (1986) [Pubmed]
  15. Regulation of ovulation by human pheromones. Stern, K., McClintock, M.K. Nature (1998) [Pubmed]
  16. Elevated urine estrogen and pregnanediol levels in daughters of breast cancer patients. Trichopoulos, D., Brown, J.B., Garas, J., Papaioannou, A., MacMahon, B. J. Natl. Cancer Inst. (1981) [Pubmed]
  17. Glucose tolerance testing in women with premenstrual syndrome. Denicoff, K.D., Hoban, C., Grover, G.N., Rubinow, D.R. The American journal of psychiatry. (1990) [Pubmed]
  18. TSH and prolactin responses to TRH in patients with premenstrual syndrome. Roy-Byrne, P.P., Rubinow, D.R., Hoban, M.C., Grover, G.N., Blank, D. The American journal of psychiatry. (1987) [Pubmed]
  19. Sex steroid receptors in human myometrium and fibroids: changes during the menstrual cycle and gonadotropin-releasing hormone treatment. Englund, K., Blanck, A., Gustavsson, I., Lundkvist, U., Sjöblom, P., Norgren, A., Lindblom, B. J. Clin. Endocrinol. Metab. (1998) [Pubmed]
  20. Clomiphene citrate attenuates hyperprolactinemia associated with ovarian hyperstimulation in the primate menstrual cycle. Simon, J.A., Gianfortoni, J.G., Hodgen, G.D. J. Clin. Endocrinol. Metab. (1988) [Pubmed]
  21. Drug-induced QT prolongation in women during the menstrual cycle. Rodriguez, I., Kilborn, M.J., Liu, X.K., Pezzullo, J.C., Woosley, R.L. JAMA (2001) [Pubmed]
  22. Hormonal status of breast cancer. I. Thoretical basis for the analysis of steroid profile. Kodama, M., Kodama, T. J. Natl. Cancer Inst. (1975) [Pubmed]
  23. Effects of the menstrual cycle on dependent variables in mood disorder research. Leibenluft, E., Fiero, P.L., Rubinow, D.R. Arch. Gen. Psychiatry (1994) [Pubmed]
  24. In vivo responses of the primate corpus luteum to luteinizing hormone and chorionic gonadotropin. Zeleznik, A.J. Proc. Natl. Acad. Sci. U.S.A. (1998) [Pubmed]
  25. Interpopulational differences in progesterone levels during conception and implantation in humans. Vitzthum, V.J., Spielvogel, H., Thornburg, J. Proc. Natl. Acad. Sci. U.S.A. (2004) [Pubmed]
  26. Progesterone implants enhance SIV vaginal transmission and early virus load. Marx, P.A., Spira, A.I., Gettie, A., Dailey, P.J., Veazey, R.S., Lackner, A.A., Mahoney, C.J., Miller, C.J., Claypool, L.E., Ho, D.D., Alexander, N.J. Nat. Med. (1996) [Pubmed]
  27. Luteal phase defects induced by an agonist of luteinizing hormone-releasing factor: a model for fertility control. Sheehan, K.L., Casper, R.F., Yen, S.S. Science (1982) [Pubmed]
  28. Surrogate embryo transfer combined with estrogen-progesterone therapy in monkeys. Implantation, gestation, and delivery without ovaries. Hodgen, G.D. JAMA (1983) [Pubmed]
  29. Comparison of prednisolone and placebo in subfertile men with antibodies to spermatozoa. Hendry, W.F., Hughes, L., Scammell, G., Pryor, J.P., Hargreave, T.B. Lancet (1990) [Pubmed]
  30. Erythrocyte filterability and heme catabolism during the menstrual cycle. Mercke, C., Lundh, B. Ann. Intern. Med. (1976) [Pubmed]
  31. The progesterone antagonist RU 486. A potential new contraceptive agent. Nieman, L.K., Choate, T.M., Chrousos, G.P., Healy, D.L., Morin, M., Renquist, D., Merriam, G.R., Spitz, I.M., Bardin, C.W., Baulieu, E.E. N. Engl. J. Med. (1987) [Pubmed]
  32. Selective inhibition of follicle-stimulating hormone secretion by estradiol. Mechanism for modulation of gonadotropin responses to low dose pulses of gonadotropin-releasing hormone. Marshall, J.C., Case, G.D., Valk, T.W., Corley, K.P., Sauder, S.E., Kelch, R.P. J. Clin. Invest. (1983) [Pubmed]
  33. Socioeconomic status, urine estrogens, and breast cancer risk. Trichopoulos, D., MacMahon, B., Brown, J. J. Natl. Cancer Inst. (1980) [Pubmed]
  34. Effects of alcohol consumption on plasma and urinary hormone concentrations in premenopausal women. Reichman, M.E., Judd, J.T., Longcope, C., Schatzkin, A., Clevidence, B.A., Nair, P.P., Campbell, W.S., Taylor, P.R. J. Natl. Cancer Inst. (1993) [Pubmed]
  35. HOXA10 is expressed in response to sex steroids at the time of implantation in the human endometrium. Taylor, H.S., Arici, A., Olive, D., Igarashi, P. J. Clin. Invest. (1998) [Pubmed]
  36. Identification of the fetal liver cytochrome CYP3A7 in human endometrium and placenta. Schuetz, J.D., Kauma, S., Guzelian, P.S. J. Clin. Invest. (1993) [Pubmed]
  37. Expression of genes that contribute to proliferative and metastatic ability in breast cancer resected during various menstrual phases. Saad, Z., Bramwell, V.H., Wilson, S.M., O'Malley, F.P., Jeacock, J., Chambers, A.F. Lancet (1998) [Pubmed]
  38. Localization, quantification, and activation of platelet-activating factor receptor in human endometrium during the menstrual cycle: PAF stimulates NO, VEGF, and FAKpp125. Ahmed, A., Dearn, S., Shams, M., Li, X.F., Sangha, R.K., Rola-Pleszczynski, M., Jiang, J. FASEB J. (1998) [Pubmed]
  39. Increased expression of transforming growth factor beta isoforms and basic fibroblast growth factor in complex hyperplasia and adenocarcinoma of the endometrium: evidence for paracrine and autocrine action. Gold, L.I., Saxena, B., Mittal, K.R., Marmor, M., Goswami, S., Nactigal, L., Korc, M., Demopoulos, R.I. Cancer Res. (1994) [Pubmed]
  40. Gastrointestinal transit: the effect of the menstrual cycle. Wald, A., Van Thiel, D.H., Hoechstetter, L., Gavaler, J.S., Egler, K.M., Verm, R., Scott, L., Lester, R. Gastroenterology (1981) [Pubmed]
  41. Cyclical variation in paroxysmal supraventricular tachycardia in women. Rosano, G.M., Leonardo, F., Sarrel, P.M., Beale, C.M., De Luca, F., Collins, P. Lancet (1996) [Pubmed]
  42. Modulation of coronary flow velocity reserve by gender, menstrual cycle and hormone replacement therapy. Hirata, K., Shimada, K., Watanabe, H., Muro, T., Yoshiyama, M., Takeuchi, K., Hozumi, T., Yoshikawa, J. J. Am. Coll. Cardiol. (2001) [Pubmed]
  43. Expression of colony-stimulating factor-1 (CSF-1) messenger RNA in human endometrial glands during the menstrual cycle: molecular cloning of a novel transcript that predicts a cell surface form of CSF-1. Pampfer, S., Tabibzadeh, S., Chuan, F.C., Pollard, J.W. Mol. Endocrinol. (1991) [Pubmed]
  44. Urinary progesterone as an index of ovulation and corpus luteal function. Chattoraj, S.C., Rankin, J.S., Turner, A.K., Lowe, E.W. J. Clin. Endocrinol. Metab. (1976) [Pubmed]
WikiGenes - Universities